Double-stranded RNA-specific editase 1 is an enzyme that in humans is encoded by the ADARB1gene.[1][2][3]
This gene encodes the enzyme responsible for pre-mRNA editing of the glutamate receptor subunit B by site-specific deamination of adenosines. Studies in rats found that this enzyme acted on its own pre-mRNA molecules to convert an AA dinucleotide to an AI dinucleotide which resulted in a new splice site. Alternative splicing of this gene results in several transcript variants, some of which have been characterized by the presence or absence of an ALU cassette insert and a short or long C-terminal region.[3]
↑Mittaz L, Scott HS, Rossier C, Seeburg PH, Higuchi M, Antonarakis SE (Jul 1997). "Cloning of a human RNA editing deaminase (ADARB1) of glutamate receptors that maps to chromosome 21q22.3". Genomics. 41 (2): 210–7. doi:10.1006/geno.1997.4655. PMID9143496.
Valenzuela A, Blanco J, Callebaut C, et al. (1997). "HIV-1 envelope gp120 and viral particles block adenosine deaminase binding to human CD26". Adv. Exp. Med. Biol. 421: 185–92. doi:10.1007/978-1-4757-9613-1_24. PMID9330696.
Melcher T, Maas S, Herb A, et al. (1996). "A mammalian RNA editing enzyme". Nature. 379 (6564): 460–4. doi:10.1038/379460a0. PMID8559253.
O'Connell MA, Gerber A, Keller W (1997). "Purification of human double-stranded RNA-specific editase 1 (hRED1) involved in editing of brain glutamate receptor B pre-mRNA". J. Biol. Chem. 272 (1): 473–8. doi:10.1074/jbc.272.1.473. PMID8995285.
Valenzuela A, Blanco J, Callebaut C, et al. (1997). "Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles". J. Immunol. 158 (8): 3721–9. PMID9103436.
Villard L, Tassone F, Haymowicz M, et al. (1997). "Map location, genomic organization and expression patterns of the human RED1 RNA editase". Somat. Cell Mol. Genet. 23 (2): 135–45. doi:10.1007/BF02679972. PMID9330641.
Hattori M, Fujiyama A, Taylor TD, et al. (2000). "The DNA sequence of human chromosome 21". Nature. 405 (6784): 311–9. doi:10.1038/35012518. PMID10830953.
Blanco J, Valenzuela A, Herrera C, et al. (2000). "The HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression". FEBS Lett. 477 (1–2): 123–8. doi:10.1016/S0014-5793(00)01751-8. PMID10899322.
Herrera C, Morimoto C, Blanco J, et al. (2001). "Comodulation of CXCR4 and CD26 in human lymphocytes". J. Biol. Chem. 276 (22): 19532–9. doi:10.1074/jbc.M004586200. PMID11278278.
Jaikaran DC, Collins CH, MacMillan AM (2002). "Adenosine to inosine editing by ADAR2 requires formation of a ternary complex on the GluR-B R/G site". J. Biol. Chem. 277 (40): 37624–9. doi:10.1074/jbc.M204126200. PMID12163487.
Slavov D, Gardiner K (2003). "Phylogenetic comparison of the pre-mRNA adenosine deaminase ADAR2 genes and transcripts: conservation and diversity in editing site sequence and alternative splicing patterns". Gene. 299 (1–2): 83–94. doi:10.1016/S0378-1119(02)01016-8. PMID12459255.